Indian Markets Wrap: Sensex, Nifty Snap 6-Week Losing Streak; IT & Pharma Lead Gains, Apollo Hospitals Shines
Benchmarks rise 1% for the week despite flat close on Thursday; Global trade tensions and U.S.–Russia talks keep investors cautious.

Sensex ended at 80,597 and Nifty at 24,631 on Aug 14, 2025, breaking a six-week losing streak with a 1% weekly gain. IT, pharma, Apollo Hospitals, and Infosys were top movers amid global trade uncertainty.
Weekend Market Wrap — Aug 14, 2025
Mumbai — Indian equities staged a quiet finish to the trading week, but the bigger story is that the Sensex and Nifty finally snapped a six-week losing streak, gaining around 1% each over the past five trading sessions.
Despite flat closing numbers on Thursday, bullish momentum in IT and pharma stocks helped offset persistent caution ahead of the U.S.–Russia presidential summit in Alaska.
Market Highlights
- Nifty 50: 24,631.30 (+0.05% daily, +1.0% weekly)
- S&P BSE Sensex: 80,597.66 (+0.07% daily, +1.0% weekly)
- Nifty Midcap 100: +0.9% weekly
- Nifty Smallcap 100: +0.7% weekly
- Market Holiday: August 15 (Independence Day)
Sectoral Performance
This week saw 14 of 16 sectors in the green, with export-heavy segments outperforming.
Sector | Weekly Change | Key Drivers |
---|---|---|
Pharma | +3.5% | U.S. revenue growth optimism, softer U.S. inflation |
IT | +1.3% | Offshore contracts, tariff truce boost |
Auto | +0.8% | Robust domestic sales, festive season build-up |
Metals | +0.5% | Commodity price recovery |
FMCG | +0.4% | Rural demand optimism |
Top Gainers of the Week
Stock | Weekly Change | Reason |
---|---|---|
Apollo Hospitals | +10.4% | Strong Q1 results, best weekly gain in ~4 years |
Sun Pharma | +6.2% | Positive U.S. generics sales outlook |
Infosys | +5.1% | JV with Telstra boosts investor confidence |
Dr Reddy’s Labs | +4.8% | New U.S. FDA approvals |
TCS | +4.2% | Large deal wins, stable margins |
Top Losers of the Week
Stock | Weekly Change | Reason |
---|---|---|
Coal India | -3.5% | Weak coal auction data |
BPCL | -2.8% | Margin concerns amid crude volatility |
UltraTech Cement | -2.5% | Rising input cost worries |
Adani Ports | -1.9% | Profit booking after recent rally |
NTPC | -1.5% | Power demand moderation |
Global Factors Driving Sentiment
- U.S.–China Tariff Truce Extension → Boosted export-heavy sectors like IT & pharma.
- Softer U.S. Inflation → Raised expectations of a Fed rate cut in 2025.
- U.S.–Russia Summit on Aug 15 → Investors on edge over potential impact on India-U.S. trade ties.
- Tariff Risk → U.S. duties on Indian imports increased to 50% due to Russian oil purchases.
“Any breakthrough in the summit could be a game-changer, removing secondary tariffs and improving export margins,” analysts said.
Technical Outlook
- Nifty 50 Support: 24,450
- Nifty 50 Resistance: 24,750
- Momentum indicators suggest sideways movement until global cues clear.
- Short-term strategy: Stock-specific approach over index chasing.
What’s Next for Markets?
- August 15 U.S.–Russia talks: Could spark volatility if tariff tensions rise.
- U.S. Fed policy signals: Possible rate cut may strengthen FII inflows.
- Domestic earnings season: Stock-specific action likely to dominate.